Status:
COMPLETED
Observational Study in Real Life to Describe the Libicare® Effectiveness in Female Sexual Dysfunction.
Lead Sponsor:
Procare Health Iberia S.L.
Conditions:
Female Sexual Dysfunction
Eligibility:
FEMALE
45-65 years
Brief Summary
The decrease or absence sexual desire and arousal is the alteration of the sexual sphere that women most commonly refer to in adulthood and old age. Many women can refer a decrease or absence of desir...
Detailed Description
The main objective is to describe the effectivity of LIBICARE® in the improvement of desire and sexual arousal in women between 45 and 65 years old, in real life. The secondary objectives of the stud...
Eligibility Criteria
Inclusion
- Women between 45 and 65 years old, both ages included.
- Women who refer decreased desire and / or sexual arousal.
- Women who will receive LIBICARE® by prescription of their doctor regardless of their participation or not in the study.
- Women who have given their informed consent in writing.
Exclusion
- Women who suffer or have suffered breast cancer.
- Women in anticoagulant treatment.
- Women who, in the opinion of the researcher, cannot follow the study procedures.
- Women not be able to understand the nature of the study, the procedures to follow or who are not authorized to sign an informed consent
- Pregnant or lactating women
- Women with allergies to any of the components of Libicare®
Key Trial Info
Start Date :
October 29 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 15 2021
Estimated Enrollment :
185 Patients enrolled
Trial Details
Trial ID
NCT04124640
Start Date
October 29 2019
End Date
November 15 2021
Last Update
December 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Palacios de Salud y Medicina de la Mujer
Madrid, Spain, 41720